TerrAscend (TSNDF) Change in Accured Expenses (2021 - 2024)
TerrAscend (TSNDF) reported Change in Accured Expenses of $85000.0 for Q4 2024, up 102.35% year-over-year from $42005.7 in Q1 2024, and up 34.92% quarter-over-quarter from $63000.0 in Q3 2024.
TerrAscend (TSNDF) Change in Accured Expenses (2021 - 2024) Analysis & Trends
TerrAscend (TSNDF) has 4 years of Change in Accured Expenses data on file, last reported at $85000.0 in Q4 2024.
- Change in Accured Expenses for Q4 2024 came in at $85000.0, up 102.35% year-over-year; the trailing twelve-month figure through Dec 2024 was -$388000.0 (up 81.26% YoY), and the FY2024 annual result was -$388000.0, up 81.26% from the prior year.
- Change in Accured Expenses climbed to $85000.0 in Q4 2024 per TSNDF's latest filing, from $63000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $17.8 million in Q4 2021 and troughed at -$9.9 million in Q2 2022.
- A 4-year average of $117692.3 and a median of -$14000.0 in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses soared 136.23% in 2023, then sank 3735.71% in 2024.
- A 4-year view of Change in Accured Expenses shows it stood at $17.8 million in 2021, then sank by 123.66% to -$4.2 million in 2022, then grew by 14.39% to -$3.6 million in 2023, then surged by 102.35% to $85000.0 in 2024.
- Business Quant data shows TSNDF's Change in Accured Expenses at $85000.0 in Q4 2024, $63000.0 in Q3 2024, and $1000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 85,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Dec 31, 2023 | -3.61 Mn |
| Dec 31, 2023 | -3.61 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | -159,000.00 |
| Jun 30, 2023 | -159,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -4.22 Mn |
| Dec 31, 2022 | -4.22 Mn |
| Sep 30, 2022 | 726,000.00 |
| Sep 30, 2022 | 726,000.00 |